BioSTAR^® bioabsorbable septal repair implant

References

• Billinger K, Ostermayer S, Carminati M et al. HELEX septal occluder for transcatheter closure of patent foramen ovale: multicentre experience. EuroIntervention1, 465–471 (2006).
   PubMedGoogle Scholar
• Buscheck F, Sievert H, Kleber F et al. Patent foramen ovale using the premere device: the results of the CLOSEUP trial. J. Interv. Cardiol.19(4), 328–333 (2006).
   PubMedGoogle Scholar
• Meier JM, Berger A, Delabays A et al. Percutaneous closure of patent foramen ovale: head-to-head comparison of two different devices. EuroIntervention1(1), 22–26 (2005).
   Google Scholar
• Donti A, Giardini A, Salomone L, Formigari R, Picchio FM. Transcatheter patent foramen ovale closure using the premere PFO occlusion system. Catheter Cardiovasc. Interv.68(5), 736–740 (2006).
   PubMed Web of Science ®Google Scholar
• Alaeddini J, Feghali G, Jenkins S et al. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J. Invasive Cardiol.18(8), 365–368 (2006).
   PubMedGoogle Scholar
• Hill SL, Berul CI, Patel HT et al. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J. Interv. Card. Electrophysiol.4(3), 469–474 (2000).
   PubMed Web of Science ®Google Scholar
• Kiblawi FM, Sommer RJ, Levchuck SG. Transcatheter closure of patent foramen ovale in older adults. Catheter Cardiovasc. Interv.68(1), 136–142 (2006).
   PubMed Web of Science ®Google Scholar
• Post MC, Van Deyk K, Budts W. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome. Acta cardiol.60(5), 515–519 (2005).
   PubMed Web of Science ®Google Scholar
• Amin Z, Hijazi ZM, Bass JL et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc. Interv.63(4), 496–502 (2004).
   PubMed Web of Science ®Google Scholar
• Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J. Am. Coll. Cardiol.45(8), 1213–1218 (2005).
   PubMed Web of Science ®Google Scholar
• Preventza O, Sampath-Kumar S, Wasnick J, Gold JP. Late cardiac perforation following transcatheter atrial septal defect closure. Ann. Thorac. Surg.77(4), 1435–1437 (2004).
   PubMed Web of Science ®Google Scholar
• Sherman JM, Hagler DJ, Cetta F. Thrombosis after septal closure device placement: a review of the current literature. Catheter Cardiovasc. Interv.63(4), 486–489 (2004).
   PubMed Web of Science ®Google Scholar
• Anzai H, Child J, Natterson B et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am. J. Cardiol.93(4), 426–431 (2004).
   PubMed Web of Science ®Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J. Am. Coll. Cardiol.43(2), 302–309 (2004).
   PubMed Web of Science ®Google Scholar
• Lai DW, Saver JL, Araujo JA, Reidl M, Tobis J. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. Catheter Cardiovasc. Interv.66(3), 424–426 (2005).
   PubMed Web of Science ®Google Scholar
• Wertman B, Azarbal B, Riedl M, Tobis J. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J. Am. Coll. Cardiol.47(6), 1226–1227 (2006).
   PubMed Web of Science ®Google Scholar
• Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart93(4), 444–449 (2006).
   PubMed Web of Science ®Google Scholar
• Colombo A, Karvouni E. Biodegradable stents : “fulfilling the mission and stepping away”. Circulation102(4), 371–373 (2000).
   PubMed Web of Science ®Google Scholar
• Waksman R. Update on bioabsorbable stents: from bench to clinical. J. Interv. Cardiol.19(5), 414–421 (2006).
   PubMedGoogle Scholar
• Ruge H, Wildhirt SM, Libera P et al. Images in cardiovascular medicine. Left atrial thrombus on atrial septal defect closure device as a source of cerebral emboli 3 years after implantation. Circulation112(10), e130–e131 (2005).
   Google Scholar
• Cotts T, Strouse PJ, Graziano JN. Late migration of a Sideris buttoned device for occlusion of atrial septal defect. Catheter Cardiovasc. Interv.68(5), 754–757 (2006).
   PubMed Web of Science ®Google Scholar
• Solomon SB. The future of interventional cardiology lies in the left atrium. Int. J. Cardiovasc. Intervent.6(3–4), 101–106 (2004).
   PubMedGoogle Scholar
• Rao PS. Summary and comparison of atrial septal defect closure devices. Curr. Interv. Cardiol. Rep.2(4), 367–376 (2000).
   PubMedGoogle Scholar
• Ebeid MR. Percutaneous catheter closure of secundum atrial septal defects: a review. J. Invasive Cardiol.14(1), 25–31 (2002).
   PubMedGoogle Scholar
• Sommer RJ. Patent foramen ovale: a primer for headache physicians. Headache Currents3(2), 23–36 (2006).
   Google Scholar
• Moore P, Feldman T, Mead H et al. Novel non-implant radiofrequency energy catheter closure of patent foramen ovale in swine. J. Am. Coll. Cardiol.47(4), 249A (2006).
   Google Scholar
• Sievert H, Fischer E, Heinisch C et al. Transcatheter closure of patent foramen ovale without an implant. initial clinical experience. Circulation116(15), 1701–1706 (2007).
   PubMed Web of Science ®Google Scholar
• Schneider B, Bauer R. Is surgical closure of patent foramen ovale the gold standard for treating interatrial shunts? An echocardiographic follow-up study. J. Am. Soc. Echocardiog.18(12), 1385–1391 (2005).
   PubMed Web of Science ®Google Scholar
• Homma S, Di Tullio MR, Sacco RL et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke28(12), 2376–2381 (1997).
   PubMed Web of Science ®Google Scholar
• Patten BM. Developmental defects at the foramen ovale. Am. J. Pathol.14, 135–161 (1938).
   PubMedGoogle Scholar
• Gross P. The patency of the so-called ‘anatomically open but functionally closed’ foramen ovale. Am. Heart J.10, 101–109 (1934).
   Google Scholar
• Patten BM. The closure of the foramen ovale. Am. J. Anat.48, 19–44 (1931).
   Google Scholar
• Schroeckenstein RF, Wasenda GJ, Edwards JE. Valvular competent patent foramen ovale in adults. Minn. Med.55(1), 11–13 (1972).
   PubMedGoogle Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc.59(1), 17–20 (1984).
   PubMed Web of Science ®Google Scholar
• Webster MW, Chancellor AM, Smith HJ et al. Patent foramen ovale in young stroke patients. Lancet2(8601), 11–12 (1988).
   PubMed Web of Science ®Google Scholar
• Cabanes L, Mas JL, Cohen A et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke24(12), 1865–1873 (1993).
   PubMed Web of Science ®Google Scholar
• Lechat P, Mas JL, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke. N. Engl. J. Med.318(18), 1148–1152 (1988).
   PubMed Web of Science ®Google Scholar
• Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology52(8), 1622–1625 (1999).
   PubMed Web of Science ®Google Scholar
• Marshall AC, Lock JE. Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure. Am. Heart J.140(2), 303–307 (2000).
   PubMed Web of Science ®Google Scholar
• Ho SY, McCarthy KP, Rigby ML. Morphological features pertinent to interventional closure of patent oval foramen. J. Interv. Cardiol.16(1), 33–38 (2003).
   PubMedGoogle Scholar
• Topaz O, Edwards JE, Bojack-Mackey S, Titus JL. Aneurysm of fossa ovalis in adults: a pathologic study. Cardiovasc. Pathol.12(4), 219–225 (2003).
   PubMed Web of Science ®Google Scholar
• El Said HG, McMahon CJ, Mullins CE et al. Patent foramen ovale morphology and impact on percutaneous device closure. Pediatr. Cardiol.26(1), 62–65 (2005).
   PubMed Web of Science ®Google Scholar
• Hara H, Virmani R, Ladich E et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J. Am. Coll. Cardiol.46(9), 1768–1776 (2005).
   PubMed Web of Science ®Google Scholar
• Lucas JF, Radtke WA, Bandisode VM, Fairbrother DL, Shirali GS. Characteristics of the interatrial communication in patients undergoing transcatheter device closure of atrial septal defects for cryptogenic stroke. Echocardiography (Mount Kisco, NY, USA 22(10), 814–817 (2005).
   PubMedGoogle Scholar
• McMahon CJ, El Said HG, Mullins CE. Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale. Heart88(2), E3 (2002).
   PubMed Web of Science ®Google Scholar
• Ruiz CE, Alboliras ET, Pophal SG. The puncture technique: A new method for transcatheter closure of patent foramen ovale. Catheter Cardiovasc. Interv.53(3), 369–372 (2001).
   PubMed Web of Science ®Google Scholar
• Chintala K, Turner D, Leaman S et al. Use of balloon pull-through technique to assist in CardioSEAL device closure of patent foramen ovale. Catheter Cardiovasc. Interv.60, 101–106 (2003).
   PubMed Web of Science ®Google Scholar
• Levine RA, Weyman AE, Dinsmore RE et al. Noninvasive tissue characterization: diagnosis of lipomatous hypertrophy of the atrial septum by nuclear magnetic resonance imaging. J. Am. Coll. Cardiol.7(3), 688–692 (1986).
   PubMed Web of Science ®Google Scholar
• Zanchetta M, Rigatelli G, Pedon L et al. Role of intracardiac echocardiography in atrial septal abnormalities. J. Interv. Cardiol.16(1), 63–77 (2003).
   PubMedGoogle Scholar
• Mullen MJ, Hildick-Smith D, De Giovanni JV et al. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation114(18), 1962–1967 (2006).
   PubMed Web of Science ®Google Scholar
• Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med.345(24), 1740–1746 (2001).
   PubMed Web of Science ®Google Scholar
• Berthet K, Lavergne T, Cohen A et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke31(2), 398–403 (2000).
   PubMed Web of Science ®Google Scholar
• Meier B. Iatrogenic atrial septal defect, erosion of the septum primum after device closure of a patent foramen ovale as a new medical entity. Catheter Cardiovasc. Interv.68(1), 165–168 (2006).
   PubMed Web of Science ®Google Scholar
• Cooke JC, Gelman JS, Harper RW. Chiari network entanglement and herniation into the left atrium by an atrial septal defect occluder device. J. Am. Soc. Echocardiog.12(7), 601–603 (1999).
   PubMed Web of Science ®Google Scholar
• Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch. Intern. Med.159(8), 813–818 (1999).
   PubMed Web of Science ®Google Scholar
• Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann. Intern. Med.117(6), 461–465 (1992).
   PubMed Web of Science ®Google Scholar
• Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke. N. Engl. J. Med.353(22), 2361–2372 (2005).
   PubMed Web of Science ®Google Scholar
• Bridges ND, Hellenbrand W, Latson L et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation86(6), 1902–1908 (1992).
   PubMed Web of Science ®Google Scholar
• Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med.139(9), 753–760 (2003).
   PubMed Web of Science ®Google Scholar
• Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc. Interv.68(5), 741–746 (2006).
   PubMed Web of Science ®Google Scholar
• Harrer JU, Wessels T, Franke A et al. Stroke recurrence and its prevention in patients with patent foramen ovale. Can. J. Neurol. Sci.33(1), 39–47 (2006).
   PubMed Web of Science ®Google Scholar
• Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J. Am. Coll. Cardiol.44(4), 750–758 (2004).
   PubMed Web of Science ®Google Scholar
• Del Sette M, Angeli S, Leandri M et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovascular dis.8(6), 327–330 (1998).
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet356(9242), 1648–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J. Interv. Cardiol.16(1), 39–42 (2003).
   PubMedGoogle Scholar
• Schwerzmann M, Wiher S, Nedeltchev K et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology62(8), 1399–1401 (2004).
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Cardiol.45(4), 493–495 (2005).
   PubMed Web of Science ®Google Scholar
• Azarbal B, Tobis J, Suh W et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J. Am. Coll. Cardiol.45(4), 489–492 (2005).
   PubMed Web of Science ®Google Scholar
• Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology62(8), 1439–1440 (2004).
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am. Heart J.151(4), 921–925 (2006).
   Web of Science ®Google Scholar
• Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke37(2), 430–434 (2006).
   PubMed Web of Science ®Google Scholar
• Guerin P, Lambert V, Godart F et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multicentric French registry. Cardiovasc. Intervent. Radiol.28(2), 164–168 (2005).
   PubMed Web of Science ®Google Scholar
• Cartoni D, De Castro S, Valente G et al. Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. Am. J. Cardiol.94(2), 270–273 (2004).
   PubMed Web of Science ®Google Scholar
• Torti SR, Billinger M, Schwerzmann M et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur. Heart J.25(12), 1014–1020 (2004).
   PubMed Web of Science ®Google Scholar
• Shanoudy H, Soliman A, Raggi P et al. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest113(1), 91–96 (1998).
   PubMed Web of Science ®Google Scholar
• Beelke M, Angeli S, Del Sette M et al. Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep25(8), 856–862 (2002).
   PubMed Web of Science ®Google Scholar
• Beelke M, Angeli S, Del Sette M et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Medicine4(3), 219–223 (2003).
   PubMed Web of Science ®Google Scholar
• Agnoletti G, Iserin L, Lafont A, Sidi D, Desnos M. Obstructive sleep apnoea and patent foramen ovale: successful treatment of symptoms by percutaneous foramen ovale closure. J. Interv. Cardiol.18(5), 393–395 (2005).
   PubMedGoogle Scholar
• Johansson MC, Eriksson P, Peker Y et al. The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea. Eur. Respir. J.29(1), 149–155 (2007).
   PubMed Web of Science ®Google Scholar
• Purandare N, Oude Voshaar RC, Burns A, Velupandian UM, McCollum C. Paradoxical embolization: a potential cause of cerebral damage in Alzheimer's disease? Neurological Res.28(6), 679–684 (2006).
   PubMed Web of Science ®Google Scholar
• Klotzsch C, Sliwka U, Berlit P, Noth J. An increased frequency of patent foramen ovale in patients with transient global amnesia. Analysis of 53 consecutive patients. Arch. Neurol.53(6), 504–508 (1996).
   PubMedGoogle Scholar
• Asirdizer M, Tatlisumak E. The role of eustachian valve and patent foramen ovale in sudden death. J. Clin. Forensic Med.13(5), 262–267 (2006).
   PubMedGoogle Scholar
• Allemann Y, Hutter D, Lipp E et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA296(24), 2954–2958 (2006).
   PubMed Web of Science ®Google Scholar
• Hacievliyagil SS, Gunen H, Kosar FM, Sahin I, Kilic T. Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease. Resp. Med.100(5), 903–910 (2006).
   PubMed Web of Science ®Google Scholar
• Soliman A, Shanoudy H, Liu J, Russell DC, Jarmukli NF. Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. J. Am. Soc. Echocardiog.12(2), 99–105 (1999).
   PubMed Web of Science ®Google Scholar
• Giberti L, Bino G, Tanganelli P. Pregnancy, patent foramen ovale and stroke: a case of pseudoperipheral facial palsy. Neurol. Sci.26(1), 43–45 (2005).
   PubMed Web of Science ®Google Scholar
• Agostoni P, Gasparini G, Destro G. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman. Heart90(3), e12 (2004).
   Web of Science ®Google Scholar
• Engelhardt M, Folkers W, Brenke C et al. Neurosurgical operations with the patient in sitting position: analysis of risk factors using transcranial Doppler sonography. Br. J. Anaesth.96(4), 467–472 (2006).
   PubMed Web of Science ®Google Scholar
• Forteza AM, Rabinstein A, Koch S et al. Endovascular closure of a patent foramen ovale in the fat embolism syndrome: changes in the embolic patterns as detected by transcranial Doppler. Arch. Neurol.59(3), 455–459 (2002).
   PubMedGoogle Scholar
• Marini C, Miniati M, Ambrosino N et al. Dyspnoea and hypoxaemia after lung surgery: the role of interatrial right-to-left shunt. Eur. Respir. J.28(1), 174–181 (2006).
   PubMed Web of Science ®Google Scholar
• Djaiani G, Phillips-Bute B, Podgoreanu M et al. The association of patent foramen ovale and atrial fibrillation after coronary artery bypass graft surgery. Anesth. Analg.98(3), 585–589 (2004).
   PubMed Web of Science ®Google Scholar
• Hausdorf G. StarFlex ASD closure: deployment, techniques, equipment. J. Interv. Cardiol.14(1), 69–76 (2001).
   PubMedGoogle Scholar
• Hausdorf G, Kaulitz R, Paul T, Carminati M, Lock J. Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder). Am. J. Cardiol.84(9), 1113–1116, A1110 (1999).
   PubMed Web of Science ®Google Scholar
• Abraham GA, Murray J, Billiar K, Sullivan SJ. Evaluation of the porcine intestinal collagen layer as a biomaterial. J. Biomed. Mater. Res.51(3), 442–452 (2000).
   PubMed Web of Science ®Google Scholar
• Billiar K, Murray J, Laude D, Abraham G, Bachrach N. Effects of carbodiimide crosslinking conditions on the physical properties of laminated intestinal submucosa. J. Biomed. Mater. Res.56(1), 101–108 (2001).
   PubMed Web of Science ®Google Scholar
• Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl. Immunol.12(3–4), 367–377 (2004).
   PubMed Web of Science ®Google Scholar
• Badylak SF, Tullius R, Kokini K et al. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J. Biomed. Mater. Res.29(8), 977–985 (1995).
   PubMed Web of Science ®Google Scholar
• Huynh T, Abraham G, Murray J et al. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nature biotechnol.17(11), 1083–1086 (1999).
   PubMed Web of Science ®Google Scholar
• Rosen M, Roselli EE, Faber C et al. Small intestinal submucosa intracardiac patch: an experimental study. Surgical innovation12(3), 227–231 (2005).
   PubMedGoogle Scholar
• Jux C, Wohlsein P, Bruegmann M et al. A new biological matrix for septal occlusion. J. Interv. Cardiol.16(2), 149–152 (2003).
   PubMedGoogle Scholar
• Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J. Am. Coll. Cardiol.48(1), 161–169 (2006).
   PubMed Web of Science ®Google Scholar
• Bailey AJ. Perspective article: the fate of collagen implants in tissue defects. Wound Repair Regen8(1), 5–12 (2000).
   PubMed Web of Science ®Google Scholar
• Everts V, van der Zee E, Creemers L, Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem. J.28(4), 229–245 (1996).
   PubMedGoogle Scholar
• Allman AJ, McPherson TB, Badylak SF et al. Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation71(11), 1631–1640 (2001).
   PubMed Web of Science ®Google Scholar
• Martin D, Williams S. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial. Biochem. Eng. J.16, 97–105 (2003).
   Web of Science ®Google Scholar